IFNG and cancer: As a result, conditions with Th1 immune activation such as cancers, viral infections, or IFNγ therapy lead to lowered serum tryptophan levels, increased kynurenine/tryptophan ratio, and possibly a shift in the balance from serotonin to kynurenine biosynthesis [75, 76].